Baxter famotidine injection package insert

buy now

Looking for reliable and effective famotidine injection for your medical practice? Look no further than Baxter’s famotidine injection package. With a trusted name in healthcare, Baxter provides high-quality medications to meet your patients’ needs. Our famotidine injection package insert offers comprehensive information on dosing, administration, and precautions to ensure optimal patient care. Trust Baxter for all your medical supply needs.

Key Information About Baxter Famotidine Injection Package Insert

The Baxter Famotidine Injection is a pharmaceutical product used for gastric acid suppression. It is commonly employed to treat ulcers, gastroesophageal reflux disease (GERD), and other conditions that involve excessive stomach acid production.

The active ingredient in Baxter Famotidine Injection is famotidine, a histamine H2-receptor antagonist that works by reducing the production of stomach acid. This medication helps to alleviate symptoms such as heartburn, acid indigestion, and stomach ulcers.

The Baxter Famotidine Injection package insert contains detailed information about the formulation, composition, dosage, and administration of the product. It is essential to read this document carefully before using the medication to ensure safe and effective treatment.

Product Name Baxter Famotidine Injection
Active Ingredient Famotidine
Indications Treatment of ulcers, GERD, and other conditions associated with excess stomach acid
Mechanism of Action Histamine H2-receptor antagonist

It is important to consult a healthcare provider or pharmacist for specific dosing instructions and to report any adverse reactions or side effects while using Baxter Famotidine Injection. Do not discontinue the medication without medical advice.

See also  Best way to take famotidine

Indications and Usage

The Baxter Famotidine Injection is indicated for the treatment of active duodenal ulcer in adult patients. It is also indicated for the maintenance therapy of duodenal ulcer in adult patients at reduced dosage after healing of an active ulcer. Furthermore, it is indicated for the treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome, in adult patients.

Important Information

  • It is important to follow the dosage and administration guidelines provided by your healthcare provider.
  • Do not exceed the recommended dosage without consulting a healthcare professional.

Indications and Usage

The Baxter famotidine injection is indicated for the treatment of active duodenal ulcer in adults. It is also indicated for the short-term treatment of erosive esophagitis due to gastroesophageal reflux disease (GERD) in adults and pediatric patients.

It is important to follow the dosage and administration guidelines provided by your healthcare provider to ensure the safe and effective use of Baxter famotidine injection.

Dosage and Administration

Dosage and Administration

It is important to follow the dosing and administration instructions provided by your healthcare provider or as outlined in the Baxter famotidine injection package insert. Famotidine injection is typically administered intravenously, and the dosage may vary depending on the patient’s condition and response to treatment.

Before administering the injection, healthcare providers should carefully inspect the solution for any discoloration or particulate matter. If any abnormalities are observed, the injection should not be used.

  • The recommended adult dosage for famotidine injection for the treatment of conditions such as gastroesophageal reflux disease (GERD) or ulcers is typically 20 mg every 12 hours.
  • For critically ill patients or those with more severe conditions, higher doses may be required. The dosage and frequency of administration should be determined by the healthcare provider based on the individual patient’s needs.
  • Patients with impaired renal function may require dosage adjustments to prevent the accumulation of famotidine in the body.
See also  Famotidine before or after meal

It is important to administer the injection slowly over a specified period to minimize the risk of adverse reactions. Healthcare providers should also monitor the patient’s response to treatment and adjust the dosage if necessary.

Always consult with a healthcare provider for specific dosing recommendations and follow the instructions provided in the Baxter famotidine injection package insert.

Warnings and Precautions

It is important to consider the following warnings and precautions when using Baxter Famotidine Injection:

  • Do not use this medication if you are allergic to famotidine or other similar medications.
  • Inform your healthcare provider about any existing medical conditions, especially kidney or liver disease.
  • Monitor for signs of an allergic reaction, such as rash, itching, swelling, or difficulty breathing.
  • Avoid using famotidine injection if you are pregnant or breastfeeding without consulting your doctor.
  • Be cautious when administering famotidine to elderly patients as they may be more sensitive to its effects.

It is crucial to follow the prescribed dosage and administration instructions to prevent adverse reactions and ensure the safe and effective use of Baxter Famotidine Injection.

Adverse Reactions

Adverse reactions to Baxter Famotidine Injection may include:

System Organ Class Adverse Reaction
Cardiac Disorders Arrhythmias, palpitations
Gastrointestinal Disorders Diarrhea, constipation, nausea, vomiting
Nervous System Disorders Headache, dizziness, confusion
Skin and Subcutaneous Tissue Disorders Rash, pruritus, urticaria

Patients should be monitored for these adverse reactions during treatment with Baxter Famotidine Injection and appropriate action taken if necessary.

Storage and Handling

Storage and Handling

The Baxter famotidine injection should be stored at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). It is recommended to protect the product from light. Do not freeze. The solution should be inspected visually for particulate matter and discoloration prior to administration. If any of these are observed, the product should not be used.

See also  Famotidine alternatives
Storage Conditions Handling Instructions
Room Temperature Store at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F)
Light Protection Protect the product from light
Freezing Do not freeze
Visual Inspection Inspect visually for particulate matter and discoloration prior to administration